Dr. Lesley Kaye, MD

Clinical Neurophysiology Aurora, CO Female
NPI: 1902225675
Total Payments
$80,110
2024 Payments
$26,905
Companies
4
Transactions
235
Medicare Patients
226
Medicare Billing
$35,249

Payment Breakdown by Category

Research$79,203 (98.9%)
Food & Beverage$907.17 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $79,203 225 98.9%
Food and Beverage $907.17 10 1.1%

Payments by Type

Research
$79,203
225 transactions
General
$907.17
10 transactions

Top Paying Companies

Company Total Records Latest Year
NEUROPACE, INC. $79,490 227 $0 (2024)
UCB, Inc. $355.15 4 $0 (2023)
SK Life Science, Inc. $148.48 3 $0 (2021)
Medtronic, Inc. $116.54 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $26,905 94 NEUROPACE, INC. ($26,905)
2023 $32,199 64 NEUROPACE, INC. ($32,097)
2022 $20,622 72 NEUROPACE, INC. ($20,488)
2021 $383.99 5 SK Life Science, Inc. ($148.48)

All Payment Transactions

235 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
10/03/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $526.00 Research
Study: Post Approval Study • Category: Epilepsy
10/03/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $521.30 Research
Study: Post Approval Study • Category: Epilepsy
10/03/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $493.00 Research
Study: Post Approval Study • Category: Epilepsy
10/03/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $493.00 Research
Study: Post Approval Study • Category: Epilepsy
10/03/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $493.00 Research
Study: Post Approval Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $1,275.00 Research
Study: Post Approval Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $650.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $460.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $460.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $460.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $345.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $288.40 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $212.80 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $212.80 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Post Approval Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $150.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $75.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $42.00 Research
Study: Nautilus Study • Category: Epilepsy
09/30/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) — Cash or cash equivalent $42.00 Research
Study: Nautilus Study • Category: Epilepsy
123…10»

Research Studies & Clinical Trials

Study Name Company Amount Records
Post Approval Study NEUROPACE, INC. $43,013 151
Nautilus Study NEUROPACE, INC. $36,190 74

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 51 82 $67,041 $10,281
2022 5 112 151 $104,256 $17,343
2021 3 63 78 $45,098 $7,626
Total Patients
226
Total Services
311
Medicare Billing
$35,249
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2023 22 51 $52,989 $8,127 15.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 11 11 $6,292 $1,158 18.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 20 $7,760 $995.29 12.8%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2022 27 56 $58,184 $9,428 16.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 18 20 $11,440 $1,953 17.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 13 17 $9,724 $1,772 18.2%
95718 Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional Facility 2022 12 13 $8,723 $1,421 16.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 16 18 $6,984 $1,275 18.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 11 12 $4,656 $796.57 17.1%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 15 15 $4,545 $696.55 15.3%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 41 52 $26,180 $4,652 17.8%
95720 Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report Facility 2021 11 15 $15,585 $2,506 16.1%
95816 Measurement and recording of brain wave (eeg) activity, awake and drowsy Facility 2021 11 11 $3,333 $467.40 14.0%

About Dr. Lesley Kaye, MD

Dr. Lesley Kaye, MD is a Clinical Neurophysiology healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1902225675.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lesley Kaye, MD has received a total of $80,110 in payments from pharmaceutical and medical device companies, with $26,905 received in 2024. These payments were reported across 235 transactions from 4 companies. The most common payment nature is "" ($79,203).

As a Medicare-enrolled provider, Kaye has provided services to 226 Medicare beneficiaries, totaling 311 services with total Medicare billing of $35,249. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Clinical Neurophysiology
  • Other Specialties Epilepsy
  • Location Aurora, CO
  • Active Since 04/10/2014
  • Last Updated 12/07/2021
  • Taxonomy Code 2084N0600X
  • Entity Type Individual
  • NPI Number 1902225675

Products in Payments

  • RNS Neurostimulator Kit (Device) $79,490
  • Briviact (Drug) $148.86
  • Percept (Device) $116.54
  • Fintepla (Drug) $87.32

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Clinical Neurophysiology Doctors in Aurora

Kenneth Tyler, Md, MD

Clinical Neurophysiology — Payments: $6,349

Clinical Neurophysiology $6,349

Jonathan Woodcock, Md, MD

Clinical Neurophysiology — Payments: $2,387

Clinical Neurophysiology $2,387

Mesha-Gay Brown, Md, MD

Clinical Neurophysiology — Payments: $2,042

Clinical Neurophysiology $2,042

Jessica Sanders, Md, MD

Clinical Neurophysiology — Payments: $267.49

Clinical Neurophysiology $267.49

Christopher Filley, Md, MD

Clinical Neurophysiology — Payments: $220.40

Clinical Neurophysiology $220.40

Robert Neumann, Md, MD

Clinical Neurophysiology — Payments: $86.63

Clinical Neurophysiology $86.63